Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Treatment
1.2.2. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Celiac Disease Treatment Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
Chapter 4. Celiac Disease Treatment Market: Treatment Business Analysis
4.1. Treatment Market Share, 2024 & 2030
4.2. Treatment Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
4.4. Vitamins & Minerals
4.4.1. Vitamins & Minerals Market, 2018 - 2030 (USD Million)
4.5. Gluten Degrading Enzymes
4.5.1. Gluten Degrading Enzymes Market, 2018 - 2030 (USD Million)
4.6. Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others)
4.6.1. Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others) Market, 2018 - 2030 (USD Million)
4.7. Other Treatments
4.7.1. Other Treatments Market, 2018 - 2030 (USD Million)
Chapter 5. Celiac Disease Treatment Market: Distribution Channel Business Analysis
5.1. Distribution Channel Market Share, 2024 & 2030
5.2. Distribution Channel Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
5.4. Hospital Pharmacies
5.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
5.5. Retail Pharmacies
5.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
5.6. Other Distribution Channels
5.6.1. Other Distribution Channels Market, 2018 - 2030 (USD Million)
Chapter 6. Celiac Disease Treatment Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Canada Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. Mexico Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Insights
6.5.2.4. UK Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Insights
6.5.3.4. Germany Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Insights
6.5.4.4. France Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Regulatory Framework
6.5.5.3. Competitive Insights
6.5.5.4. Italy Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Regulatory Framework
6.5.6.3. Competitive Insights
6.5.6.4. Spain Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.7. Norway
6.5.7.1. Key Country Dynamics
6.5.7.2. Regulatory Framework
6.5.7.3. Competitive Insights
6.5.7.4. Norway Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key Country Dynamics
6.5.8.2. Regulatory Framework
6.5.8.3. Competitive Insights
6.5.8.4. Denmark Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.9. Sweden
6.5.9.1. Key Country Dynamics
6.5.9.2. Regulatory Framework
6.5.9.3. Competitive Insights
6.5.9.4. Sweden Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Insights
6.6.2.4. Japan Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Insights
6.6.3.4. China Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Insights
6.6.4.4. India Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Insights
6.6.5.4. South Korea Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.6. Australia
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Insights
6.6.6.4. Australia Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Insights
6.6.7.4. Thailand Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Framework
6.8.4.3. Competitive Insights
6.8.4.4. UAE Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Regulatory Framework
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Teva Pharmaceutical Industries Ltd.
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Amgen Inc.
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Amneal Pharmaceuticals LLC.
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. GLENMARK PHARMACEUTICALS LTD.
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Takeda Pharmaceutical Company Limited
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Hikma Pharmaceuticals PLC
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Viatris Inc.
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Zydus Pharmaceuticals, Inc.
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Novartis Pharmaceuticals Corporation
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. BioLineRx
7.5.10.1. Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global celiac disease treatment market, by region, 2018 - 2030 (USD Million)
Table 4 Global celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 5 Global celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 6 North America celiac disease treatment market, by country, 2018 - 2030 (USD Million)
Table 7 North America celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 8 North America celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 9 U.S. celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 10 U.S. Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 11 Canada celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 12 Canada celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 13 Mexico celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 14 Mexico celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 15 Europe celiac disease treatment market, by country, 2018 - 2030 (USD Million)
Table 16 Europe celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 17 Europe celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 18 UK celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 19 UK Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 20 Germany celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 21 Germany celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 22 France celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 23 France Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 24 Italy celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 25 Italy celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 26 Spain celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 27 Spain celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 28 Norway celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 29 Norway Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 30 Denmark celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 31 Denmark celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 32 Sweden celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 33 Sweden celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 34 Asia Pacific celiac disease treatment market, by country, 2018 - 2030 (USD Million)
Table 35 Asia Pacific celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 36 Asia Pacific celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 37 Japan celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 38 Japan celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 39 China celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 40 China celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 41 India celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 42 India celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 43 Australia celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 44 Australia celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 45 South Korea celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 46 South Korea celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 47 Thailand celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 48 Thailand celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 49 Latin America celiac disease treatment market, by country, 2018 - 2030 (USD Million)
Table 50 Latin America celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 51 Latin America celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 52 Brazil celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 53 Brazil celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 54 Argentina celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 55 Argentina celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa Celiac disease treatment market, by country, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 58 Middle East & Africa celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 59 South Africa celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 60 South Africa celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 63 UAE celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 64 UAE celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 65 Kuwait celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 66 Kuwait celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Celiac disease treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Treatment and distribution channel outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Celiac disease treatment market dynamics
Fig. 12 Celiac disease treatment market: Porter’s five forces analysis
Fig. 13 Celiac disease treatment market: PESTLE analysis
Fig. 14 Celiac disease treatment market: Treatment segment dashboard
Fig. 15 Celiac disease treatment market: Treatment market share analysis, 2024 & 2030
Fig. 16 Vitamins & minerals market, 2018 - 2030 (USD Million)
Fig. 17 Gluten degrading enzymes market, 2018 - 2030 (USD Million)
Fig. 18 Symptomatic treatment (anti-inflammatory drugs, antihistamines, others) market, 2018 - 2030 (USD Million)
Fig. 19 Other treatments market, 2018 - 2030 (USD Million)
Fig. 20 Celiac disease treatment market: Distribution channel segment dashboard
Fig. 21 Celiac disease treatment market: Distribution channel market share analysis, 2024 & 2030
Fig. 22 Hospital pharmacies market, 2018 - 2030 (USD Million)
Fig. 23 Retail pharmacies market, 2018 - 2030 (USD Million)
Fig. 24 Other distribution channels market, 2018 - 2030 (USD Million)
Fig. 25 Celiac disease treatment market revenue, by region
Fig. 26 Regional marketplace: Key takeaways
Fig. 27 Regional marketplace: Key takeaways
Fig. 28 North America celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 29 U.S. country dynamics
Fig. 30 U.S. celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 31 Canada country dynamics
Fig. 32 Canada celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 33 Mexico country dynamics
Fig. 34 Mexico celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 35 Europe celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 36 UK country dynamics
Fig. 37 UK celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 38 Germany country dynamics
Fig. 39 Germany celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 40 France country dynamics
Fig. 41 France celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 42 Italy country dynamics
Fig. 43 Italy celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 44 Spain country dynamics
Fig. 45 Spain celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 46 Norway country dynamics
Fig. 47 Norway celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 48 Sweden country dynamics
Fig. 49 Sweden celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 50 Denmark country dynamics
Fig. 51 Denmark celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 52 Asia Pacific celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 53 Japan country dynamics
Fig. 54 Japan celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 55 China country dynamics
Fig. 56 China celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 57 India country dynamics
Fig. 58 India celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 59 Australia country dynamics
Fig. 60 Australia celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 61 South Korea country dynamics
Fig. 62 South Korea celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 63 Thailand country dynamics
Fig. 64 Thailand celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 65 Latin America celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 66 Brazil country dynamics
Fig. 67 Brazil celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 68 Argentina country dynamics
Fig. 69 Argentina celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 70 MEA celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 71 South Africa country dynamics
Fig. 72 South Africa celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 73 Saudi Arabia country dynamics
Fig. 74 Saudi Arabia celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 75 UAE country dynamics
Fig. 76 UAE celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 77 Kuwait country dynamics
Fig. 78 Kuwait celiac disease treatment market, 2018 - 2030 (USD Million)
Fig. 79 Company categorization
Fig. 80 Company market position analysis
Fig. 81 Strategic framework